SnapMD is a Los Angeles–based enterprise telehealth technology innovator offering a cloud-based Virtual Care Management (VCM) telehealth platform. Its white-label VCM software is HIPAA/HITECH/COPPA compliant and includes back-end systems to manage the digital health care continuum. The platform is configured to support multiple hospital and health system service lines with unique operational requirements and can be integrated with existing and future systems. The company intends to use the new funding to advance its telemedicine platform and accelerate sales and marketing efforts. SnapMD is led by president and CEO Dave Skibinski and has raised $16.3M in total capital to date. SnapMD offers a telemedicine platform designed to support standalone virtual clinics and a variety of provider workflows, and in 2016 documented more than 40 use cases for its product. The company aims to continue innovating its platform and deepen data and platform integrations. It has pursued channel partnerships to drive commercial adoption, notably with Konica Minolta and athenahealth’s More Disruption Please marketplace. SnapMD is also exploring integrations with services such as Iggby to enable physician-ordered lab studies during virtual visits. The CEO said this would be a tipping point year for telemedicine as health systems and outpatient care better define requirements and move to offer telemedicine themselves. The company has raised funding to support these priorities and expand sales through partners. SnapMD is a Los Angeles, CA-based healthcare IT company that provides a cloud-based, HIPAA-compliant private-label Virtual Care Management (VCM) telemedicine platform delivered via mobile phones, tablets and laptops. Led by CEO and co-founder Dave Skibinski and COO George Tierney, the company enables healthcare providers to engage their patients through its private-label solution. SnapMD completed the first closing of its Series A funding, raising $5.3M. The round was backed by Shea Ventures, TYLT Labs and Whittier Ventures. The company intends to use the funds to accelerate business development via direct sales and high-value channel partners and to enhance product development with core innovations to its VCM platform. SnapMD also plans to expand data integration capabilities and further scale its mobile app solutions. SnapMD provides a cloud-based telemedicine platform that enables one-on-one video, audio and text consultations between patients and their primary care and specialty care physicians. The platform supports scheduled consultations for patients undergoing active care as well as on-demand consultations to reduce avoidable emergency department visits. It can also be used for remote services such as in-school virtual clinics and to facilitate physician-to-physician communications. Led by CEO Dave Skibinski and COO George Tierney, the company intends to use the funds to expand sales, development and hiring efforts. SnapMD closed a $600K seed funding round to support those plans. The company is based in Los Angeles, CA.

Total raised

$16M

Funding rounds

4

Latest round

Series B

Latest activity

Sep 2018